STOCKS TELEGRAPH

Tag: Merger

  • CFSB Bancorp (CFSB) Soars 68% After M Merger Deal with Hometown Financial Group

    CFSB Bancorp (CFSB) Soars 68% After $44M Merger Deal with Hometown Financial Group

    CFSB Bancorp, Inc. (NASDAQ: CFSB) became the talk of the market after a stunning post-market rally. The stock closed the regular session at $8.19, posting a modest 1.87% gain. However, the real fireworks began after hours, with shares soaring 67.77% to $13.74, fueled by heavy volume of over 20,000 shares. The surge came on the heels of a major merger announcement that has investors taking notice.

    A Transformational Deal

    On May 20, 2025, CFSB Bancorp and Hometown Financial Group, Inc., the parent company of bankESB, bankHometown, and North Shore Bank, jointly announced a definitive merger agreement. Under the deal, Hometown will acquire CFSB Bancorp and its subsidiary, Colonial Federal Savings Bank, in an all-cash transaction valued at approximately $44 million.

    Shareholders of CFSB are set to receive $14.25 per share in cash, marking a significant premium over the stock’s prior trading levels. The deal, unanimously approved by both boards, is expected to close in the fourth quarter of 2025, pending shareholder and regulatory approval.

    Bigger Bank, Broader Reach

    The acquisition will result in the merger of Colonial Federal into North Shore Bank, creating a combined institution with $3.3 billion in assets and 29 retail locations across Massachusetts and southern New Hampshire. Branches in Quincy, Holbrook, and Weymouth will transition into the North Shore Bank footprint and continue to operate under the leadership of Executive Chairman Kevin M. Tierney, Sr., and CEO Michael R. Wheeler.

    The move will also expand Hometown’s presence in eastern Massachusetts, giving the company a more robust footprint in key regional markets. Once completed, Hometown Financial Group will boast nearly $6.9 billion in assets and a branch network of 56 locations spread across Massachusetts, New Hampshire, and Connecticut.

    Strategic Growth and Customer Benefits

    This marks Hometown Financial Group’s eighth strategic merger in the last decade, solidifying its position as a major regional player. Customers of Colonial Federal will gain access to a wider range of financial products, including residential mortgage offerings through Hometown Mortgage, an affiliate of Hometown Financial.

    Legal counsel for the deal was provided by Kilpatrick Townsend & Stockton LLP for Hometown and Luse Gorman, PC for CFSB Bancorp. Piper Sandler served as strategic advisor on the transaction.

    Final Thoughts

    The explosive after-hours movement in CFSB stock reflects investor enthusiasm over the value and scale of the merger. A cash-out deal at $14.25 per share not only delivers a strong premium to shareholders but also positions Hometown for expanded dominance in the Northeast. With regulatory approvals ahead, all eyes will be on this deal’s execution in the coming months—but for now, CFSB has earned a spot in the market spotlight.

  • Waddell & Reed Financial (WDR) stock rocketed in the After hours with the news of takeover

    Waddell & Reed Financial (WDR) stock rocketed in the After hours with the news of takeover

    Shares of Waddell & Reed Financial Inc. spiked enormously 48.44% in AH trading to $25.25 after a slight surge of 0.83% during the regular session in the previous close, following the news of a $1.7 billion deal has been signed by Macquarie Group Ltd. to takeover Waddell & Reed Financial Inc. inline to broaden its U.S. wealth management business.

    The Sydney-based bank said that the deal would reportedly add $68 billion wealth management unit of Waddell & Reed to Macquarie’s U.S. investment management arm. The merger will push it into the top 25 professionally operated, long-term, open-ended mutual fund managers and giving it the size and scope to compete with larger rivals.

    In recent times, asset management has witnessed a surge of consolidation, with businesses reacting to a cut-throat competition squeeze on fees and a move to passive investment management anchored by index fund giants BlackRock Inc. and Vanguard Group Inc. The high tech expenses and regulatory enforcement are also bearing on money managers.

    The investment advances its move to more predictable earnings generators for Macquarie. It is heading towards “annuity-style” firms, such as wealth management and financial services, which accounted for about 70% of the first-half earnings, and away from more conventional investment banking companies, such as trading and M&A consulting services.

    Macquarie employs about 2,700 people in the U.S., and as of Sept. 30, it managed around $205 billion in assets there.

    As profits from the market-facing units slumped 42%, the former contributed almost 70 percent of the first-half profit. The transaction would also further extend Macquarie’s global sector, which in the last half generated about 70% of overall sales, up from around 50% 12 years earlier.

  • Baidu Inc. (NASDAQ: BIDU) set to take over Joyy Inc. (NASDAQ: YY) in a bid to enter video streaming space

    Baidu Inc. (NASDAQ: BIDU) set to take over Joyy Inc. (NASDAQ: YY) in a bid to enter video streaming space

    Baidu Inc. (NASDAQ: BIDU) takes yet another step to diversify into its core search company and play catch-up in video entertainment, as the Chinese tech giant revealed it is set to take over Joyy Inc. (NASDAQ: YY) live-streaming service YY Live in China for $3.6 billion in an all-cash transaction.

    The report Baidu Inc. (NASDAQ: BIDU)shared along with its quarterly earnings is probably the best breakthrough into video streaming for the Chinese company. In this deal, YY is only selling its Chinese business to Baidu. The Company confirmed that the completion of the deal is subject to some constraints and is actually scheduled to take effect in the first half of 2021.

    The acquisition comes at a time when the search giant has been trying to battle rivals such as ByteDance, who have eaten away their online advertisement supremacy as Chinese consumers pay more attention to content recommendation apps driven by algorithms.

    Meanwhile, as its home market is saturated with video giants such as Kuaishou and TikTok’s sister Douyin, the sale enables Joyy to further emphasis on overseas expansion. Joyy has accrued more than 4 million paying viewers who watch influencers entertain and sell a variety of products on the video platform, deemed the leader in China’s live streaming industry.

    Last year, Joyy Inc. ( YY)completed a $1.45 billion buyout of Bigo, a project initiated by its own promoter to test the overseas market. Bigo runs the Bigo Live streaming service and the quick video app Likee, both of which have huge follow-ups outside China, but were recently suspended by the Indian government as border tensions flared up between India and China.

    “This acquisition would propel Baidu into a dominant live streaming network and augment our source of revenue,” Baidu’s co-founder and chief executive, Robin Li, said in a statement.

    In China’s video streaming industry, Baidu faces an enormous challenge. Kuaishou and Douyin, regarded as the top names in short videos in the region, have made live streaming an integral part of their user interface to increase monetization and user interaction (through the likes of virtual gifting).

    In June, Kuaishou hit 300 million active users daily, and in January, Douyin surpassed 400 million DAUs. In contrast, as of September, Baidu Inc. (NASDAQ: BIDU)flagship app had around 200 million DAUs. YY had about 40 million monthly concurrent users online live in the third quarter.

  • Aimmune Therapeutics [NASDAQ: AIMT] Signs Definitive Agreement With Nestle

    Aimmune Therapeutics [NASDAQ: AIMT] Signs Definitive Agreement With Nestle

    Aimmune Therapeutics, Inc. [NASDAQ: AIMT] disclosed today it has signed a definitive agreement with a wholly-owned subsidiary of Nestle S.A, Sociétés des Produits Nestlé S.A.  Sociétés des Produits Nestlé S.A to purchase Aimmune for $34.50 per share in an all-cash transaction representing the total equity value of $2.6 billion, as per the agreement.

    All the members of the board of directors of Aimmune were agreed to the agreement. Through this acquisition, both the firms will be able to create a world leader in food allergy prevention and treatment. Aimmune Therapeutics and Nestle S.A both aimed to change the lives of people around the world living with food allergies.

    Aimmune Therapeutic traded up 171.03% at $34.15 during the pre-market trading session after its agreement with Nestle S.A. AIMT had a trading volume of 1.89 million as compared to the average volume of 1.11 million.

    It has earlier closed at $12.60 and up 5.09% during its last trading session of Friday. It has recorded the day low range of $11.82 and a day high range of $12.68.

    In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $10.09 and a high of $37.00. Aimmune moved up 24.88% and moved down -65.95% from its 52-weeks low and high. Focusing on its profitability, its return on assets (ROA) is -92.70%, and return on equity (ROE) is -170.90%.

    Turing our focus on its liquidity, it has a current ratio of 7.50 and its quick ratio is 7.40. Aimmune Therapeutics has a total market capitalization of 784.73 million. It has reported the sales of 0.60 million.

    Until the completion of the transaction, Aimmune will work as an independent firm. Looking at the transaction details, Nestle S.A will start a tender offer to buy all the outstanding shares of AIMT. After the completion of the tender offer, Nestle will start the merger of Aimmune with a subsidiary of SPN.

    PALFORZIA of Aimmune is the first official treatment for peanut allergy. Palforiza is the first health product which has significant sale potential. The deal between Aimmune and SPN is anticipated to conclude in the fourth quarter of 2020.